LeterMovir CAS 917389-32-3

Pwodwi Deskripsyon:

Non pwodwi: LeterMovir CAS NON: 917389-32-3

 

Sinonim:

2-[(4S) -8-fluoro-2-[4-(3-methoxyphenyl)piperazin-1-yl] -3-[3-[2-methoxy-5-(trifluoromethyl)-phenyl]-4H-quinazolin-4-yl]asid acetic;

AIC-246;

MK8828;

 

Chimik & Pwopriyete fizik:

Aparans: Solid oswa likid

Assay: ≥99.00%

Dansite: 1.37±0.1 g / cm3 (Predicted)

Bouyi pwen: 706.5±70.0 ° C (predi)

PKa: 4.00±0.10 (predi)

Flash Point: 381.1±35.7 ° C

Vapore Presyon: 0.0±2.4 mmHg nan 25 ° C

Endeks refraksyon: 1.601

 

Letermovir se yon abitid woman nan CMV, ki vize teminase viral konpleks la epi li rete aktif kont viris ki reziste a ADN polymeras inibitor.

 

Si ou enterese nan pwodwi nou yo oswa ou gen nenpot kesyon, tanpri santi yo lib yo kontakte nou!

 

Pwodwi anba patant yo ofri pou R & D rezon selman. Sepandan, denye responsablite a bay manti selman ak achte a.

Baj popilè: letermovir cas 917389-32-3, manifaktire, founise, faktori, achte, nan stock

• On: Ropivacaine Hydrochloride CAS 132112-35-7
• Pwochen: 2-[3-Methyl-4-(2,2,2-trifluoroethoxy) -2-pyridinyl] methylthio-1H-benzimidale CAS 103577-40-8